Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,804,000 | 21,688,000 | 16,536,000 | 10,999,000 | 14,066,000 |
| Depreciation Amortization | 7,503,000 | 5,492,000 | 3,715,000 | 1,772,000 | 7,339,000 |
| Income taxes - deferred | 1,538,000 | 5,215,000 | 2,997,000 | 2,172,000 | -2,183,000 |
| Accounts receivable | -1,782,000 | -2,178,000 | -2,280,000 | -930,000 | -395,000 |
| Other Working Capital | -12,719,000 | -16,320,000 | -15,942,000 | -11,028,000 | 1,848,000 |
| Other Operating Activity | 3,186,000 | 3,324,000 | 3,026,000 | 1,189,000 | 3,591,000 |
| Operating Cash Flow | $24,530,000 | $17,221,000 | $8,052,000 | $4,174,000 | $24,266,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,112,000 | -2,587,000 | -1,506,000 | -516,000 | -3,749,000 |
| Net Acquisitions | -17,541,000 | -14,459,000 | -14,458,000 | N/A | -15,146,000 |
| Purchase Of Investment | -920,000 | -677,000 | -431,000 | -251,000 | -1,726,000 |
| Sale Of Investment | 1,661,000 | 1,442,000 | 953,000 | 218,000 | 2,462,000 |
| Other Investing Activity | -2,676,000 | -2,822,000 | -3,119,000 | 252,000 | -440,000 |
| Investing Cash Flow | $-23,588,000 | $-19,103,000 | $-18,561,000 | $-297,000 | $-18,599,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,586,000 | 10,673,000 | 9,349,000 | 8,784,000 | 15,277,000 |
| Debt Issued | 9,138,000 | 9,138,000 | 9,138,000 | 9,138,000 | 6,660,000 |
| Debt Repayment | -1,757,000 | -1,755,000 | -754,000 | -751,000 | -1,453,000 |
| Common Stock Issued | 3,418,000 | 1,831,000 | 557,000 | 450,000 | 838,000 |
| Common Stock Repurchased | -5,953,000 | -4,029,000 | -2,127,000 | -2,127,000 | -2,432,000 |
| Dividend Paid | -12,381,000 | -9,250,000 | -6,118,000 | -2,989,000 | -11,823,000 |
| Other Financing Activity | -12,590,000 | -10,778,000 | -5,288,000 | -2,083,000 | -10,199,000 |
| Financing Cash Flow | $-5,539,000 | $-4,170,000 | $4,757,000 | $10,422,000 | $-3,132,000 |
| Exchange Rate Effect | 201,000 | 178,000 | 224,000 | 70,000 | -289,000 |
| Beginning Cash Position | 24,105,000 | 24,105,000 | 24,105,000 | 24,105,000 | 21,859,000 |
| End Cash Position | 19,709,000 | 18,231,000 | 18,577,000 | 38,474,000 | 24,105,000 |
| Net Cash Flow | $-4,396,000 | $-5,874,000 | $-5,528,000 | $14,369,000 | $2,246,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,530,000 | 17,221,000 | 8,052,000 | 4,174,000 | 24,266,000 |
| Capital Expenditure | -4,832,000 | -2,995,000 | -1,838,000 | -795,000 | -4,424,000 |
| Free Cash Flow | 19,698,000 | 14,226,000 | 6,214,000 | 3,379,000 | 19,842,000 |